Live Breaking News & Updates on Biolase inc

Stay informed with the latest breaking news from Biolase inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Biolase inc and stay connected to the pulse of your community

Dental Lasers Market Size Set To Reach USD 550.5 Million By 2032, Marking A 6.7% Annual Growth Rate

According to Market.Us, the global dental lasers market was valued at USD 292.5 million in 2022, and it is projected to reach approximately USD 550.5 million by 2032. The market is anticipated to experience a compound annual growth rate (CAGR) of 6.7% from 2023 to 2032, marking the highest growth rate within this pe...

China , Thailand , Japan , Singapore , South-korea , Germany , Brazil , Vietnam , Republic-of , Canada , Russia , Saudi-arabia

BIOLASE (NASDAQ:BIOL) Earns Sell Rating from Analysts at StockNews.com

BIOLASE (NASDAQ:BIOL) Earns Sell Rating from Analysts at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Walleye-capital , Renaissance-technologies , Citadel-advisors , Biolase-inc , Company-profile , Free-report , Get-free-report , Street-corp ,

BIOLASE (NASDAQ:BIOL) Receives New Coverage from Analysts at StockNews.com

BIOLASE (NASDAQ:BIOL) Receives New Coverage from Analysts at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Biolase-inc , Walleye-capital , Citadel-advisors , Renaissance-technologies , Free-report , Get-free-report , State-street-corp , Street-corp ,

BIOLASE (NASDAQ:BIOL) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL – Get Free Report) in a note issued to investors on Tuesday. The firm set a “sell” rating on the medical technology company’s stock. BIOLASE Price Performance Shares of BIOLASE stock opened at $0.18 on Tuesday. The company has a current ratio of 1.26, a quick ratio […]

United-states , Biolase-inc , Walleye-capital , Citadel-advisors , Renaissance-technologies , Company-profile , Get-free-report , State-street-corp , Street-corp ,

Short Interest in BIOLASE, Inc. (NASDAQ:BIOL) Expands By 17.6%

BIOLASE, Inc. (NASDAQ:BIOL – Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 288,900 shares, an increase of 17.6% from the February 29th total of 245,600 shares. Based on an average daily volume of 4,800,000 shares, the […]

United-states , Biolase-inc , Citadel-advisors , Nasdaq , Renaissance-technologies , Walleye-capital , Get-free-report , State-street-corp , Street-corp , Biolase , Nasdaq-biol

BIOLASE, Inc. (NASDAQ:BIOL) Sees Large Growth in Short Interest

BIOLASE, Inc. (NASDAQ:BIOL – Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 288,900 shares, a growth of 17.6% from the February 29th total of 245,600 shares. Based on an average daily volume of 4,800,000 shares, the […]

United-states , Walleye-capital , Citadel-advisors , Biolase-inc , Nasdaq , Renaissance-technologies , Get-free-report , State-street-corp , Street-corp , Biolase , Nasdaq-biol

Why BIOLASE Shares Are Surging Friday - Biolase (NASDAQ:BIOL)

BIOLASE, Inc. shares rise 31% after better-than-expected FY23 EPS results, strong revenue growth expected in 2024 due to increased laser adoption.

John-beaver , Biolase-inc , Chief-executive-officer , Vanguard-extended-market ,